228 related articles for article (PubMed ID: 30192548)
1. Innovative DNA-Targeted Metallo-prodrug Strategy Combining Histone Deacetylase Inhibition with Oxidative Stress.
McGivern TJP; Slator C; Kellett A; Marmion CJ
Mol Pharm; 2018 Nov; 15(11):5058-5071. PubMed ID: 30192548
[TBL] [Abstract][Full Text] [Related]
2. An Endogenous Reactive Oxygen Species (ROS)-Activated Histone Deacetylase Inhibitor Prodrug for Cancer Chemotherapy.
Bhagat SD; Singh U; Mishra RK; Srivastava A
ChemMedChem; 2018 Oct; 13(19):2073-2079. PubMed ID: 30070768
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
4. Polypyridyl-Based Copper Phenanthrene Complexes: Combining Stability with Enhanced DNA Recognition.
Fantoni NZ; Molphy Z; O'Carroll S; Menounou G; Mitrikas G; Krokidis MG; Chatgilialoglu C; Colleran J; Banasiak A; Clynes M; Roche S; Kelly S; McKee V; Kellett A
Chemistry; 2021 Jan; 27(3):971-983. PubMed ID: 32519773
[TBL] [Abstract][Full Text] [Related]
5. Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release.
Daniel KB; Sullivan ED; Chen Y; Chan JC; Jennings PA; Fierke CA; Cohen SM
J Med Chem; 2015 Jun; 58(11):4812-21. PubMed ID: 25974739
[TBL] [Abstract][Full Text] [Related]
6. Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents.
Ye RR; Ke ZF; Tan CP; He L; Ji LN; Mao ZW
Chemistry; 2013 Jul; 19(31):10160-9. PubMed ID: 23828334
[TBL] [Abstract][Full Text] [Related]
7. Radical-induced DNA damage by cytotoxic square-planar copper(II) complexes incorporating o-phthalate and 1,10-phenanthroline or 2,2'-dipyridyl.
Kellett A; Howe O; O'Connor M; McCann M; Creaven BS; McClean S; Foltyn-Arfa Kia A; Casey A; Devereux M
Free Radic Biol Med; 2012 Aug; 53(3):564-76. PubMed ID: 22659117
[TBL] [Abstract][Full Text] [Related]
8. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.
Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC
Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704
[TBL] [Abstract][Full Text] [Related]
9. Efficient Palladium-Triggered Release of Vorinostat from a Bioorthogonal Precursor.
Rubio-Ruiz B; Weiss JT; Unciti-Broceta A
J Med Chem; 2016 Nov; 59(21):9974-9980. PubMed ID: 27786474
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potent histone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy.
Wen J; Bao Y; Niu Q; Yang J; Fan Y; Li J; Jing Y; Zhao L; Liu D
Eur J Med Chem; 2016 Feb; 109():350-9. PubMed ID: 26814680
[TBL] [Abstract][Full Text] [Related]
11. A new class of prophylactic metallo-antibiotic possessing potent anti-cancer and anti-microbial properties.
Ude Z; Kavanagh K; Twamley B; Pour M; Gathergood N; Kellett A; Marmion CJ
Dalton Trans; 2019 Jun; 48(24):8578-8593. PubMed ID: 30946409
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds.
Blanquart C; François M; Charrier C; Bertrand P; Gregoire M
Curr Cancer Drug Targets; 2011 Oct; 11(8):919-28. PubMed ID: 21762083
[TBL] [Abstract][Full Text] [Related]
13. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
14. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
Jang YG; Hwang KA; Choi KC
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
[TBL] [Abstract][Full Text] [Related]
15. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
Negmeldin AT; Pflum MKH
Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461
[TBL] [Abstract][Full Text] [Related]
16. A series of camptothecin prodrugs exhibit HDAC inhibition activity.
Zhu Q; Yu X; Shen Q; Zhang Q; Su M; Zhou Y; Li J; Chen Y; Lu W
Bioorg Med Chem; 2018 Sep; 26(16):4706-4715. PubMed ID: 30115492
[TBL] [Abstract][Full Text] [Related]
17. Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines.
Hanke NT; Garland LL; Baker AF
J Cancer Res Clin Oncol; 2016 Mar; 142(3):549-60. PubMed ID: 26385374
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Combination of Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Natural Flavonoid Curcumin Exhibits Anticancer and Antibacterial Activity.
Altundağ EM; Toprak K; Şanlıtürk G; Güran M; Özbilenler C; Kerküklü NR; Yılmaz AM; Yalçın AS
Anticancer Agents Med Chem; 2021; 21(10):1301-1308. PubMed ID: 33023457
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes.
Paul A; Anbu S; Sharma G; Kuznetsov ML; Koch B; Guedes da Silva MF; Pombeiro AJ
Dalton Trans; 2015 Dec; 44(46):19983-96. PubMed ID: 26523453
[TBL] [Abstract][Full Text] [Related]
20. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
You BR; Han BR; Park WH
Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
